Substance / Medication

Amlodipine besilate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Fixed-dose combination therapy of candesartan cilexetil and amlodipine besilate for the treatment of hypertension in Japan.
Yasuno Shinji, Fujimoto Akira, Nakagawa Yasuaki et al. · Expert Rev Cardiovasc Ther · 2012
PMID: 22651833Observational
Antihypertensive, Amlodipine Besilate Inhibits Growth and Biofilm of Human Fungal Pathogen Candida.
Gupta Payal, Chanda Reshmi, Rai Nishant et al. · Assay Drug Dev Technol · 2016
PMID: 27336942Other
Semisolid matrix-filled hard gelatin capsules for rapid dissolution of amlodipine besilate: Development and assessment.
Tyagi Vijay K, Singh Deshvir, Pathak Kamla · J Adv Pharm Technol Res · 2013
PMID: 23662281OtherFull text (PMC)
A single-dose, randomized, crossover bioequivalence study of levamlodipine besilate tablets in healthy subjects.
Deng Qiaohuan, Yang Debin, Cheng Yang et al. · Naunyn Schmiedebergs Arch Pharmacol · 2025
PMID: 39377925Trial
Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability.
Chhabra Gulshan, Chuttani Krishna, Mishra Anil K et al. · Drug Dev Ind Pharm · 2011
PMID: 21401341Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Amlodipine besilate (substance)
SNOMED CT
384976003
UMLS CUI
C0354468

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.